Progesterone receptor modulators and the endometrium: changes and consequences†
Open Access
- 14 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 13 (6), 567-580
- https://doi.org/10.1093/humupd/dmm023
Abstract
Progesterone receptor modulators (PRMs) have been used for contraceptive research, as well as for treatment of fibroids, endometriosis and heavy or irregular menstrual bleeding. Long-term treatment with these compounds results in changes to the endometrium resulting in potential confusion in trying to characterize endometrial biopsies. A meeting was held to discuss the properties of PRMs, the effects of perturbed hormonal control of the endometrium and the need for further understanding of the biology of progesterone receptor action to facilitate the development of new PRMs. A panel of pathologists was convened to evaluate endometrial changes associated with a minimum of three months of chronic treatment with PRMs. Four different agents were used in the treatment regimens but the pathologists were blinded to treatment regimen or agent. The panel agreed that the endometrial biopsies did not fit into a classification of either proliferative or secretory endometrium but exhibited an unusual architecture that could be characterized as glandular dilatation. There was little evidence of mitosis, consistent with a proposed anti-proliferative effect of PRMs. The panel concluded that the biopsies did not reveal evidence of safety concern and that pathologists and investigators familiar with endometrial effects of chronic PRM exposure should consider working with pharmaceutical companies and regulatory agencies to develop standard descriptions of PRM-associated endometrial changes as well as the types of histologic changes that would signal a need for intervention.Keywords
This publication has 98 references indexed in Scilit:
- Management of patients receiving long-term treatment with mifepristoneFertility and Sterility, 2005
- Progesterone-Induced Inhibition of Growth and Differential Regulation of Gene Expression in PRA- and/or PRB-Expressing Endometrial Cancer Cell LinesJournal of the Society for Gynecologic Investigation, 2005
- Benign gynecologic conditions among participants in the Breast Cancer Prevention TrialAmerican Journal of Obstetrics and Gynecology, 2005
- Antiprogestins for Contraception?Seminars in Reproductive Medicine, 2005
- Interobserver and intraobserver variability in the histological dating of the endometrium in fertile and infertile womenFertility and Sterility, 2004
- Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor AGenes, Chromosomes and Cancer, 2004
- Genomics' Role in Understanding the Pathogenesis of EndometriosisSeminars in Reproductive Medicine, 2003
- Endometrial hyperplasia and the risk of carcinomaInternational Journal of Gynecologic Cancer, 1995
- Metastatic small cell carcinoma of the endometrium: prolonged remission and possible cure following chemotherapyInternational Journal of Gynecologic Cancer, 1994
- Steroid hormone receptors in human colon cancersCancer, 1979